Praxis Precision Medicines Announces Positive Results of EEG Analysis of PRAX-628 Phase 1 Study
Composite qEEG measure showed change from placebo after first dose of 5 mg Effect in…
Composite qEEG measure showed change from placebo after first dose of 5 mg Effect in…
– First patient dosed in phase 1/2 trial of TNG462, a next-generation PRMT5 inhibitor for…
– First patient dosed in phase 1/2 trial of TNG462, a next-generation PRMT5 inhibitor for…
EMERYVILLE, Calif., Aug. 07, 2023 (GLOBE NEWSWIRE) — Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage…
EMERYVILLE, Calif., Aug. 07, 2023 (GLOBE NEWSWIRE) — Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage…
• VYJUVEK™ approved in the U.S. as the first and only topical redosable gene therapy for…
• VYJUVEK™ approved in the U.S. as the first and only topical redosable gene therapy for…
Enrollment completed in Phase 2 CHAPTER-1 prophylactic study; top-line data anticipated by YE2023 Clinical hold…
CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, Aug. 07, 2023 (GLOBE NEWSWIRE) — Centogene N.V….
Conference call and webcast to be held on Tuesday, August 22, 2023 DUBUQUE, Iowa–(BUSINESS WIRE)–Flexsteel…
ARCHER Trial Results Presented at ASRS Further Demonstrate Preservation of Visual Function in Patients with…
Early-stage startups are invited to join and gain access to a range of tools, services,…
Company strengthens expansion strategy with addition of new hires for connected solutions category, marketing, and…
Strategic hire to propel market Expansion: Rayne’s comprehensive experience to drive Sonim’s growth in key…
DeepMaterial is pioneering in the UV Curing Adhesive revolution in China Guangdong, China–(Newsfile Corp. –…
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed…
Cyrano.ai’s Scott Sandland Presents Tuesday, August 8, 2023 MIAMI–(BUSINESS WIRE)–Sensedia, a global leader in delivering…
UiPath demoing “Project Wingman” within its AI-powered automation platform at booth #400 at Ai4 2023,…
Company says new guidelines reflect investments many power generators are already making and urges industry…
Significant pipeline advancement highlighted by the initiation of BNT316/ONC-392 Phase 3 pivotal trial and multiple…